Keywords
1,4-bis(aminomethyl)benzene
AMPA receptor
cycloalkanecarboxamide
negative modulator
patch clamp
Purkinje neurons
Abstract
Bisamides of 1,4-bis(aminomethyl)benzene with cyclopropane-, cyclobutane- and cyclopentanecarboxylic acids reveal the negative modulation of kainate-induced currents in rat Purkinje neurons observed using patch clamp technique. The most pronounced effect has been found for the bisamide of cyclobutanecarboxylic acid, which blocks the currents by 41 and 49% at concentrations of 1×10−10 and 1×10−9moldm−3, respectively.
References
1.
Robbins T.W., Murphy E.R.
Trends in Pharmacological Sciences,
2006
2.
Herguedas B., García-Nafría J., Cais O., Fernández-Leiro R., Krieger J., Ho H., Greger I.H.
Science,
2016
3.
Traynelis S.F., Wollmuth L.P., McBain C.J., Menniti F.S., Vance K.M., Ogden K.K., Hansen K.B., Yuan H., Myers S.J., Dingledine R.
Pharmacological Reviews,
2010
4.
Lynch G.
Current Opinion in Pharmacology,
2004
5.
Timm D.E., Benveniste M., Weeks A.M., Nisenbaum E.S., Partin K.M.
Molecular Pharmacology,
2011
6.
Sun Y., Olson R., Horning M., Armstrong N., Mayer M., Gouaux E.
Nature,
2002
7.
Reuillon T., E. Ward S., Beswick P.
Current Topics in Medicinal Chemistry,
2016
8.
Twomey E.C., Yelshanskaya M.V., Grassucci R.A., Frank J., Sobolevsky A.I.
Nature,
2017
9.
Ring-fused thiadiazines as core structures for the development of potent AMPA receptor potentiators.
Pirotte B., Francotte P., Goffin E., Fraikin P., Danober L., Lesur B., Botez I., Caignard D.-., Lestage P., de Tullio P.
Current Medicinal Chemistry,
2010
10.
Drapier T., Geubelle P., Bouckaert C., Nielsen L., Laulumaa S., Goffin E., Dilly S., Francotte P., Hanson J., Pochet L., Kastrup J.S., Pirotte B.
Journal of Medicinal Chemistry,
2018
11.
Lauterborn J.C., Palmer L.C., Jia Y., Pham D.T., Hou B., Wang W., Trieu B.H., Cox C.D., Kantorovich S., Gall C.M., Lynch G.
Journal of Neuroscience,
2016
12.
Hanada T.
Expert Opinion on Drug Discovery,
2014
13.
Di Bonaventura C., Labate A., Maschio M., Meletti S., Russo E.
Expert Opinion on Pharmacotherapy,
2017
14.
Ruel J., Guitton M.J., Puel J.
CNS Drug Reviews,
2006
15.
Radchenko E.V., Karlov D.S., Lavrov M.I., Palyulin V.A.
Mendeleev Communications,
2017
16.
Nazarova A.A., Sedenkova K.N., Karlov D.S., Lavrov M.I., Grishin Y.K., Kuznetsova T.S., Zamoyski V.L., Grigoriev V.V., Averina E.B., Palyulin V.A.
MedChemComm,
2019
17.
Lavrov M.I., Karlov D.S., Voronina T.A., Grigoriev V.V., Ustyugov A.A., Bachurin S.O., Palyulin V.A.
Molecular Neurobiology,
2019
18.
Sedenkova K.N., Averina E.B., Nazarova A.A., Grishin Y.K., Karlov D.S., Zamoyski V.L., Grigoriev V.V., Kuznetsova T.S., Palyulin V.A.
Mendeleev Communications,
2018
19.
Lavrov M.I., Veremeeva P.N., Karlov D.S., Zamoyski V.L., Grigoriev V.V., Palyulin V.A.
Mendeleev Communications,
2019
20.
Temnyakova N.S., Vasilenko D.A., Lavrov M.I., Karlov D.S., Grishin Y.K., Zamoyski V.L., Grigoriev V.V., Averina E.B., Palyulin V.A.
Mendeleev Communications,
2021